Abstract:Objective: This study aims to investigate the relationship between thyroid function and prognosis in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). Methods: According to the thyroid function status of the patients at admission, they were divided into the euthyroid group (Group A), subclinical hyperthyroidism group (Group B), subclinical hypothyroidism group (Group C), and low T3 group (Group D). The clinical data of the four patient groups were compared. The logistic regression model was used to analyze the relationship between thyroid function and postoperative outcomes in patients with ACS undergoing PCI. Results: A total of 200 ACS patients who underwent PCI treatment in our hospital from January 2022 to October 2023 were selected as the research population. The incidences of subclinical hyperthyroidism, subclinical hypothyroidism, and low T3 syndrome were 17.00% (34/200), (36/200), and 29.50% (59/200), respectively. Univariate analysis of variance showed significant differences in age, diabetes, smoking history, systolic pressure and heart rate at admission, shock index, blood urea nitrogen (BUN), Cr, glucose (GLU), fibrinogen (FIB), glycosylated hemoglobin (HbA1c), creatine kinase isoenzyme (CK-MB), and CRP among all groups (p < 0.05). Thyroid function markers differed significantly across the groups (p < 0.001). Specifically, Group B exhibited the lowest thyroid stimulating hormone (TSH) levels (0.23 ± 0.09 mIU/L), whereas Group C displayed the highest (8.05 ± 3.72 mIU/L). Group D showed the lowest free triiodothyronine (FT3) levels (2.74 ± 0.51 pmol/L), and Group B had the highest free thyroxine (FT4) levels (16.31 ± 2.62 pmol/L). A significant difference in the incidences of cardiovascular death and heart failure was observed among the four groups (p < 0.05). Notably, Group D showed higher incidences of cardiovascular death (11.86%) and heart failure (50.85%). Similarly, at 1-year follow-up, a significant difference in the incidences of cardiovascular death and heart failure were found among the four groups (p < 0.05). Specially, Group D exhibited higher rates of cardiovascular death (15.25%) and heart failure (27.12%). Logistic regression analyses highlighted FT3 as a significant predictor of adverse events during hospitalization (OR = 0.335, 95% CI: 0.222–0.506, p < 0.001), while TSH emerged as an independent risk factor for adverse events during 1-year follow-up (OR = 1.136, 95% CI: 1.040–1.240, p = 0.005). Conclusion: Patients with ACS have a higher incidence of mild thyroid dysfunction. Compared with patients with euthyroid function, patients with low triiodothyronine (T3) syndrome have a worse prognosis after PCI treatment. Serum FT3 concentration and TSH can be used as predictors of poor prognosis in ACS patients.

Clinical Study on the Changes of PerioperativeSerum Thyroid Hormone During Heart Surgery

A Study Towards the Association Between Perioperative Serum Levels of FT3,FT4,TSH and rT3 in CPB and Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass

Effect of Preoperative Thyroid Hormone Supplement on Cardiopulmonary Bypass in Children

The effects of thyroid hormone and TSH on the human body by elective surgery and its clinical significance

The discussion of the relationship between cardiopulmonary bypass and postoperative thyroid function changes in pediatric congenital heart disease, and the analysis of oral thyroid hormone therapy and cardiac prognosis

Monitoring of Plasma Thyroid Hormone Concentrations and Circulatory Functions in Patients with Organic Heart Diseases During Cesearean Section

Impact of Basic Thyroid Hormone Level on Prognosis of Patients With Heart Transplantation

Coronary artery bypass surgery in patients with angina pectoris and hypothyroidism

Change of thyroid hormone in senile patients with coronary heart disease and chronic congestive heart failure

Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery

Effects of Cardiopulmonary Bypass on Plasma Levels of Procalcitonin and Cytokines

Association between Thyroid Function and Postoperative Outcomes in Patients with Acute Coronary Syndrome after Treatment with PCI: A Retrospective Study

Perioperative changes of myocardial enzymes and troponin I in patients undergoing noncardiac surgery

The Effect of Hypophysin on Hemodynamics in Patients with Severe Hypotension after Cardiopulmonary Bypass

Changes of Thyroid Function in Patients with Chronic Obstructive Pulmonary Disease and Its Clinical Significance

Effects of Hypophysin on Coronary Blood Flow in Patients with Hypotension after Cardiopulmonary Bypass

[The behavior of free thyroxine and triiodothyronine concentrations after short-term balanced inhalation anesthesia]

The Relationship Between Thyroid Hormone Levels and Cardiac Function in Patients with Acute Myocardial Infarction

Patterns and Determinants of Change in Cortisol Levels and Thyroid Function as a Function of Cardiac Risk in Children Undergoing Cardiac Surgery

Changes of serum calcium, phosphates and parathyroid function after thyroidectomy

Influnce of Thyroid Hormone Replacement Therapy on Lipid and Heart Function of Elderly Patients with Hypothyroidism